NASDAQ: BCTXBriacell Therapeutics Corp Stock Ownership - Who owns Briacell Therapeutics?
Insider buying vs selling
Have Briacell Therapeutics Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when BCTX insiders and whales buy or sell their stock.
BCTX Shareholders
What type of owners hold Briacell Therapeutics Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Marc Lustig | 10.57% | 1,640,000 | $9.61M | Insider |
| Kj Harrison Partners Inc | 10.36% | 1,607,027 | $9.42M | Institution |
| Lynwood Capital Management Inc | 3.96% | 615,000 | $3.60M | Institution |
| Wasatch Advisors Inc | 2.30% | 356,498 | $2.09M | Institution |
| Williams V. Williams | 0.96% | 149,636 | $876.87k | Insider |
| Redmond Asset Management LLC | 0.89% | 137,942 | $808.34k | Institution |
| Jamieson Bondarenko | 0.77% | 119,856 | $702.36k | Insider |
| Sabby Management LLC | 0.37% | 57,589 | $337.47k | Institution |
| Jane Street Group LLC | 0.32% | 50,284 | $294.66k | Institution |
| Summit Trail Advisors LLC | 0.23% | 35,000 | $205.10k | Institution |
BCTX vs Biotech Stocks
Briacell Therapeutics Stock Ownership FAQ
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.